DAVID MARSH: Open Payments
NPI 1588627822 · MARYVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,906 in 78 payments from 13 companies in 2025. Trend: 2023 $864 · 2024 $1,310 · 2025 $1,906
Food & beverage: $1,821Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $428 |
| ABBVIE INC. | 24 | $428 |
| Madrigal Pharmaceuticals | 3 | $216 |
| Ardelyx, Inc. | 7 | $160 |
| Aimmune Therapeutics, Inc. | 7 | $157 |
| PFIZER INC. | 7 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $98 |
| Gilead Sciences, Inc. | 4 | $84 |
| Lilly USA, LLC | 4 | $82 |
| Novo Nordisk Inc | 3 | $67 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, IBSRELA, ZENPEP, XELJANZ, MAVYRET, OMVOH.
Industry payments across TN — which companies pay providers there.
